Sign in
8-K

Current Report

Summit Therapeutics Inc. Filed Acc 0001193125-25-178022

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d56029d8k.htm…